Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability

Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability

Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic forms and low and pH-dependent solubility. A mucoa...

Full description

Bibliographic Details
Main Authors:	Viviana De Caro, Alessia Ajovalasit, Flavia Maria Sutera, Denise Murgia, Maria Antonietta Sabatino, Clelia Dispenza
Format:	Article
Language:	English
Published:	MDPI AG 2017-06-01
Series:	Pharmaceutics
Subjects:	mucoadhesive film sublingual absorption amorphous solid dispersion furosemide bioavailability transmucosal delivery
Online Access:	http://www.mdpi.com/1999-4923/9/3/22

Similar Items

Evaluation of Carbomer, CMC and HPMC on Dissolution and Bioadhesion of buccoadhesive Cinnamaldehyde Tablets
by: Majid Saeedi, et al.
Published: (2018-02-01)

Development of a Mucoadhesive Vehicle Based on Lyophilized Liposomes for Drug Delivery through the Sublingual Mucosa
by: María José De Jesús Valle, et al.
Published: (2022-07-01)

Comparative Study of Different Combinational Mucoadhesive Formulations of Sumatriptan-Metoclopramide
by: Mitra Jelvehgari, et al.
Published: (2016-03-01)

Fast Dissolving Sublingual Strips: A Novel Approach for the Delivery of Isosorbide Dinitrate
by: Marzieh Fathei, et al.
Published: (2019-12-01)

Synthesis of Methacryloylated Hydroxyethylcellulose and Development of Mucoadhesive Wafers for Buccal Drug Delivery
by: Fhataheya Buang, et al.
Published: (2022-12-01)

Mucosal Adjuvants Delivered by a Mucoadhesive Patch for Sublingual Administration of Subunit Vaccines
by: Claire Monge, et al.
Published: (2022-11-01)

Control of odontogenic pain by diclofenac and meloxicam mucoadhesive patches: A randomized, double-blinded, placebo-controlled, preliminary study
by: Pratik R Pipalia, et al.
Published: (2016-01-01)

Furosemide in Hypovolemic shock
by: Khalid Ali Khaleel
Published: (2020-12-01)

Pharmacokinetic study of furosemide incorporated PLGA microspheres after oral administration to rat
by: Katayoun Derakhshandeh, et al.
Published: (2016-10-01)

Exploitation of Design-of-Experiment Approach for Design and Optimization of Fast-Disintegrating Tablets for Sublingual Delivery of Sildenafil Citrate with Enhanced Bioavailability Using Fluid-Bed Granulation Technique
by: Amer S. AlAli, et al.
Published: (2021-06-01)

Silica Nanoparticles in Transmucosal Drug Delivery
by: Twana Mohammed M. Ways, et al.
Published: (2020-08-01)

Buccal Thin Films as Potent Permeation Enhancers for Cytisine Transbuccal Delivery
by: Viviana De Caro, et al.
Published: (2022-11-01)

Recent Advancement in Chitosan-Based Nanoparticles for Improved Oral Bioavailability and Bioactivity of Phytochemicals: Challenges and Perspectives
by: Syed Sarim Imam, et al.
Published: (2021-11-01)

Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers
by: Mohammed H. Elkomy, et al.
Published: (2017-01-01)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
by: Hasan Barzegari, et al.
Published: (2021-03-01)

Spray-dried co-amorphous Tadalafil ternary mixtures: a promising platform towards the enhancement of solubility and bioavailability
by: Hoda El-Maradny, et al.
Published: (2023-01-01)

Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability
by: Liu P, et al.
Published: (2020-07-01)

Polymer–Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole
by: Disang Feng, et al.
Published: (2018-04-01)

Subcutaneous Furosemide in Heart Failure
by: Domenic A. Sica, MD, et al.
Published: (2018-02-01)

Furosemide versus Hydralazine for Managing Post Partum Hypertension in Severe Preeclampsia: A Comparative Study
by: M Behrashi, et al.
Published: (2012-10-01)

Furosemide: Would it help to improve the lungs as evaluated by sonography and compliance during aortic coarctation surgery
by: Ahmed Kareem Mohammed, et al.
Published: (2019-01-01)

Evaluation of sufentanil sublingual tablet 30 mcg for perioperative pain management of in-office rhinology procedures
by: Ashley Sikand, et al.
Published: (2023-06-01)

THE DISSOLUTION AND DIFFUSION OF FUROSEMIDE ON SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS)
by: Iis Wahyuningsih, et al.
Published: (2017-04-01)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
by: Georgiana Frățilă, et al.
Published: (2023-11-01)

Administration of Intravenous Furosemide in Patients with Acute Infection: Patient Characteristics and Impact on In-Hospital Outcome
by: Nir Levi, et al.
Published: (2023-05-01)

Furosemide use in Italian neonatal intensive care units: a national survey
by: Valeria Anna Manfredini, et al.
Published: (2020-06-01)

Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation
by: Wang Y, et al.
Published: (2020-10-01)

Effect of furosemide in the treatment of high-altitude pulmonary edema
by: Dava Tenzing, et al.
Published: (2024-03-01)

Simultaneous Determination of Sulfanilamide and Furosemide by Using Derivative Spectrophotometry
by: Samar A. Darweesh
Published: (2017-03-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Morphometric characterization of sexual differences in the rat sublingual gland Caracterização morfométrica das diferenças sexuais na glândula sublingual de rato
by: Marta da Cunha Lima, et al.
Published: (2004-03-01)

Furosemide prevents membrane KCC2 downregulation during convulsant stimulation in the hippocampus
by: Lulan Chen, et al.
Published: (2022-06-01)

Goal-directed diuresis: A case - control study of continuous furosemide infusion in critically ill trauma patients
by: Daniel Dante Yeh, et al.
Published: (2015-01-01)

Effect of nitroprusside on furosemide-induced skeletal teratogenicity in rat fetuses
by: Mahmood Khaksary Mahabady, et al.
Published: (2016-01-01)

Microextraction of Furosemide from Human Serum and Its Fluorimetric Determination
by: Akbar Rezazadeh, et al.
Published: (2018-03-01)

Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate
by: Allam A, et al.
Published: (2016-08-01)

Practice parameters for sublingual immunotherapy
by: C. Ortolani, et al.
Published: (2016-02-01)

Mechanisms of increased bioavailability through amorphous solid dispersions: a review
by: Andreas Schittny, et al.
Published: (2020-01-01)

Transfusi Albumin dan Furosemid pada Pasien Sindrom Nefrotik Anak dengan Edema
by: Meita Dwi Utami, et al.
Published: (2017-06-01)

The Association Between Sublingual Varices and Cardiovascular Risk Factors
by: Bergh H, et al.
Published: (2022-04-01)